VCAN and neoplasm: Thus, taken together, these studies establish that both intact versican and a proteolytic degradation product of versican have immunomodulatory properties and suggest that the anti-tumor properties of versikine might antagonize the pro-tumor properties of intact versican (13, 23, 73, 75, 188).